UK MHRA Adapts Inspections Program To Account For Increase In Pharmacovigilance Outsourcing
Executive Summary
As drug companies increasingly outsource their pharmacovigilance activities to third party organizations, the UK regulator has made changes to its inspections program so that all affected marketing authorization holders are kept abreast of any problems identified at contract service providers.